Cargando…
p90 ribosomal S6 kinase: a potential therapeutic target in lung cancer
A global survey of cancer has shown that lung cancer is the most common cause of the new cancer cases and cancer deaths in men worldwide. The mortality from lung cancer is more than the combined mortality from breast, prostate and colorectal cancers. The two major histological types of lung cancer a...
Autores principales: | Poomakkoth, Noufira, Issa, Aya, Abdulrahman, Nabeel, Abdelaziz, Somaia Gamal, Mraiche, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721001/ https://www.ncbi.nlm.nih.gov/pubmed/26791782 http://dx.doi.org/10.1186/s12967-016-0768-1 |
Ejemplares similares
-
Na(+)/H(+) Exchanger Isoform 1 Induced Cardiomyocyte Hypertrophy Involves Activation of p90 Ribosomal S6 Kinase
por: Jaballah, Maiy, et al.
Publicado: (2015) -
Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis
por: Abdelaziz Mohamed, Iman, et al.
Publicado: (2019) -
Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases
por: Fruergaard, Marlene Uglebjerg, et al.
Publicado: (2023) -
Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases
por: Andersen, Jacob Lauwring, et al.
Publicado: (2018) -
The p90 Ribosomal S6 Kinase (RSK) Is a Mediator of Smooth Muscle Contractility
por: Artamonov, Mykhaylo, et al.
Publicado: (2013)